Search

Your search keyword '"Gabdoulline, Razif"' showing total 18 results

Search Constraints

Start Over You searched for: Author "Gabdoulline, Razif" Remove constraint Author: "Gabdoulline, Razif" Publisher american society of hematology Remove constraint Publisher: american society of hematology
18 results on '"Gabdoulline, Razif"'

Search Results

1. Clonal Relapse Dynamics in Acute Myeloid Leukemia Following Allogeneic Hematopoietic Cell Transplantation

2. DEK-NUP214 Acute Myeloid Leukemia Depends on CRM1 In Vivo

3. Rapid and Reproducible Karyotyping with Nanopore Sequencing in AML Patients

4. Fla-IDA Chemotherapy with or without Venetoclax in Patients with Relapsed/Refractory Acute Myeloid Leukemia

5. Clonal Relapse Dynamics in Acute Myeloid Leukemia Following Allogeneic Hematopoietic Cell Transplantation

6. Molecular Response Patterns in Relapsed/Refractory AML Patients Treated with Selinexor and Chemotherapy

7. Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations

8. IDH Mutations Are Associated with an Increased Risk of Coronary Artery Disease and Cardiotoxicity in Patients with Established AML

9. Post Transplantation Measurable Residual Disease (MRD) Monitoring Using Next-Generation Sequencing Is Highly Predictive for Relapseafter Allogeneic Stem Cell Transplantation

10. Hematologic Recovery from Venetoclax-Containing Regimens in Relapsed/Refractory Acute Myeloid Leukemia Patients Depending on Prior Allogeneic Hematopoietic Cell Transplantation

11. Prolyl Hydroxylase 3 (Phd3) Is a Therapeutic Target in Isocitrate Dehydrogenase 1 (IDH1) Mutated Acute Myeloid Leukemia

13. Frequency and Clinical Characteristics Associated with Putative CAR Targets ADGRE2, CCR1, CD70, and LILRB2 in Acute Myeloid Leukemia

14. The Role of PPM1D Mutations in Lenalidomide Resistance and Progression in Patients with MDS and Deletion of Chromosome 5q

15. Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML

16. Pan-Mutant-IDH1 Inhibitor Bay-1436032 Is Highly Effective Against Human IDH1 Mutant Acute Myeloid Leukemia In Vivo

17. Characteristics and Prognosis of AML Patients with or without a History of Clonal Hematopoiesis

18. Molecular Predictors of Outcome in Patients with MDS and AML Following MDS after Allogeneic Hematopoietic Stem Cell Transplantation

Catalog

Books, media, physical & digital resources